Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
06/2005
06/23/2005US20050137212 Hppars activators
06/23/2005US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels
06/22/2005EP1543096A1 Alkyl-succinhydrazide additives for lubricants
06/22/2005EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
06/22/2005CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use
06/21/2005US6908935 Calcium receptor modulating agents
06/16/2005WO2005054199A1 Tubulin inhibitors
06/16/2005US20050131226 Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
06/16/2005US20050130976 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130975 Phthalazine, hydralazine derivative; antihypertensive; extended shell life
06/16/2005US20050130943 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005CA2857067A1 Tubulin inhibitors
06/16/2005CA2545422A1 Tubulin inhibitors
06/15/2005EP1541198A1 Cycloalkyl compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
06/15/2005EP1539709A1 Azaisoquinoline derivatives as matrix metalloproteinase inhibitors
06/15/2005CN1628109A Novel aryl- and heteroarylpiperazines
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626532A Amide compounds
06/09/2005WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051870A2 Hydrazides and derivatives production process from hydrazines and dicarboxylic acids
06/09/2005WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545659A1 Bicyclic inhibitors of mek
06/08/2005EP1537117A1 Benzotriazabicyclic derivatives and use thereof as beta-lactamase inhibitors and anti-bacterial agents
06/08/2005EP1537098A1 Monocyclic derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005CN1205190C Process for preparation of 3(2H)-pyridazinone-4-subtd. amino-5-chloro-deriv.
06/07/2005US6903220 Synthesis of chiral 2-alkyl amino acids
06/07/2005US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/07/2005US6903107 Serine protease inhibitor
06/07/2005US6903098 Use of phthalazine derivatives
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/02/2005WO2005049581A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/02/2005WO2005049573A1 Phenyl derivatives as ppar agonists
06/02/2005CA2545193A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/01/2005EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
06/01/2005EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
06/01/2005CN1204126C Process for preparing pyridazin-3-one derivs.
05/2005
05/31/2005US6900194 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
05/26/2005US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample
05/25/2005EP1532120A1 Phenylpyridazine derivatives as ligands for gaba receptors
05/25/2005DE10347383A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors
05/19/2005WO2005035500A3 Therapeutic agents useful for treating pain
05/19/2005US20050107388 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain
05/19/2005DE10347386A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors
05/19/2005DE10346939A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases
05/18/2005CN1616437A Racemization method of 6-4-(4-amino pheny)-4, 5-dihydro-5-methyl-3-(2H)-pyridazinone
05/17/2005US6894048 Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/12/2005WO2003006454A8 Heterocyclic carboxamides and their use as fungicides
05/12/2005US20050101521 Bind as ligands to human peroxisome proliferator activated receptor to activate receptor and thereby exhibit potent effects of decreasing neutral fat, cholesterol, and blood sugar; for example, 2-[[4-ethoxy-3-[[[4-(2-pyridyloxy)phenyl]carbonylamino]methyl]phenyl]methyl]butyric acid; diabetes treatment
05/12/2005CA2542536A1 Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
05/11/2005EP1529530A1 Compounds affecting glucokinase
05/11/2005EP1529037A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
05/05/2005US20050096337 for example (2-(3-methoxy-propyl)-4-{methyl-[2-methyl-6-(4-trifluoromethyl-phenyl)-pyridin-3-ylmethyl]-amino}-phenoxy)-acetic acid; Peroxisome Proliferator Activated Receptor (PPAR) activators; treating diabetes, dyslipidemia, cardiovascular disorders, polycystic ovary syndrome, proliferative disorders
05/04/2005EP1527052A1 3-heterocyclyl substituted benzoic acid derivatives
05/04/2005EP1341539B1 Anti-inflammatory agents
05/04/2005CN1199957C 'Sqiqu site' derivative and its preparing method as well as its activity of anti asthma
05/03/2005US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors
04/2005
04/28/2005WO2005037844A1 Substituted phenyl fused heterocycles as high efficiency herbicides
04/28/2005WO2005037793A1 Cyclopentene compounds
04/28/2005US20050090559 Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents
04/27/2005CN1610669A Heteroaryl-substituted aminocyclohexane derivatives
04/27/2005CN1609110A High efficiency substituted benzene fused heterocycle herbicides
04/26/2005US6884477 Electroluminescence device using liquid crystal compound
04/21/2005WO2005035518A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
04/21/2005WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/21/2005WO2005035500A2 Therapeutic agents useful for treating pain
04/21/2005WO2005034939A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
04/21/2005WO2005013907A3 Pyrrolo[1,2-b]pyridazine derivatives
04/21/2005US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
04/21/2005US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
04/21/2005US20050085480 Water-soluble phenylpyridazine compounds and compositions containing the same
04/21/2005US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants
04/21/2005CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/21/2005CA2539878A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
04/21/2005CA2539587A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
04/20/2005CN1197864C Process for preparation of pyrazolo pyridazine derivatives
04/14/2005WO2005033105A2 Vanilloid receptor ligands and their use in treatments
04/14/2005WO2005011653A3 Pyridazine derivatives and their use as therapeutic agents
04/14/2005US20050080260 Preparation of prodrugs for selective drug delivery
04/14/2005US20050080119 Diaminopropionic acid derivatives
04/14/2005US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
04/14/2005US20050080096 Condensed heterocyclic compounds
04/14/2005CA2540640A1 Vanilloid receptor ligands and their use in treatments
04/13/2005CN1606611A Alkyl succinite hydrazide additive for lubricant
04/12/2005US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine
04/12/2005US6878709 Treating acute and chronic inflammatory disorders and cancer.
04/12/2005US6878704 Heterocyclic mutilin esters and their use as antibacterials
04/12/2005US6878702 Anti-inflammatory agents
04/07/2005WO2005030830A1 Multifunctional monomers containing bound poragens and polyarylene compositions therefrom
04/07/2005WO2005030794A2 Hemiasterlin derivatives and uses thereof
04/07/2005WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo
04/07/2005US20050075323 Beta3 adrenergic receptor agonists and uses thereof
04/07/2005US20050074470 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 85